London, UK -- 07/10/08 --
Smith & Nephew appoints Non-Executive Director
10 July 2008
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology
business, announces the appointment of an additional Non-Executive
Director to the Board.
Joseph C. Papa, aged 52, and based in Michigan is Chairman of Perrigo
Company. Perrigo is a leading global healthcare supplier that develops,
manufactures and distributes over-the-counter and prescription
pharmaceuticals, nutritional products, active pharmaceutical
ingredients and consumer products. Joe has considerable experience in
sales and marketing and has held senior management positions with
Cardinal Health, Watson Pharmaceuticals, G.D. Searle and Novartis.
Joe will join the Board on 1 August 2008.
He has no details to disclose under paragraph 9.6.13 (2) to 9.6.13 (6)
of The Listing Rules.
John Buchanan, Chairman of Smith & Nephew, said today: "We are
delighted that Joe has agreed to join the Board. He will bring
additional international experience in the medical technology
industry. We are looking forward to working with him."
Enquiries
Investors
Liz Hewitt Tel: +44 (0)20 7401 7646
Smith & Nephew
Group Director Corporate Affairs
Media
Jon Coles Tel: +44 (0)20 7404 5959
Brunswick - London
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies,
Endoscopy and Advanced Wound Management products. Smith & Nephew is a
global leader in arthroscopy and advanced wound management and is one
of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The
Company prides itself on the strength of its relationships with its
surgeons and professional healthcare customers, with whom its name is
synonymous with high standards of performance, innovation and trust.
The Company operates in 32 countries around the world. Annual sales in
2007 were USD3.4 billion.
About Perrigo Company
Perrigo Company is a leading global healthcare supplier that develops,
manufactures and distributes over-the-counter (OTC) and prescription
pharmaceuticals, nutritional products, active pharmaceutical
ingredients (API) and consumer products. The Company is the world's
largest manufacturer of OTC pharmaceutical products for the store brand
market. The Company's primary markets and locations of manufacturing
facilities are the United States, Israel, Mexico and the United
Kingdom. Visit Perrigo on the Internet
(http://www.perrigo.com).
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contacts:
RNS
Customer
Services
0044-207797-4400
Email Contact
http://www.rns.com
